- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x CUE: Coumestrol(Non-covalent)
CUE.1: 11 residues within 4Å:- Chain A: N.154, F.159, G.198, G.199, F.205, S.209, Y.212, I.213, M.227, A.228
- Ligands: GOL.7
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:F.159, A:Y.212, A:I.213, A:A.228
- Hydrogen bonds: A:Y.212, A:M.227
- pi-Stacking: A:Y.212, A:Y.212
CUE.9: 11 residues within 4Å:- Chain B: N.154, F.159, G.198, G.199, F.205, S.209, Y.212, I.213, M.227, A.228
- Ligands: GOL.15
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:F.159, B:Y.212, B:I.213, B:A.228
- Hydrogen bonds: B:M.227
- pi-Stacking: B:Y.212, B:Y.212
CUE.17: 11 residues within 4Å:- Chain C: N.154, F.159, G.198, G.199, F.205, S.209, Y.212, I.213, M.227, A.228
- Ligands: GOL.23
8 PLIP interactions:8 interactions with chain C- Hydrophobic interactions: C:F.159, C:Y.212, C:I.213, C:A.228
- Hydrogen bonds: C:Y.212, C:M.227
- pi-Stacking: C:Y.212, C:Y.212
CUE.25: 11 residues within 4Å:- Chain D: N.154, F.159, G.198, G.199, F.205, S.209, Y.212, I.213, M.227, A.228
- Ligands: GOL.31
7 PLIP interactions:7 interactions with chain D- Hydrophobic interactions: D:F.159, D:Y.212, D:I.213, D:A.228
- Hydrogen bonds: D:M.227
- pi-Stacking: D:Y.212, D:Y.212
- 4 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.2: 4 residues within 4Å:- Chain A: K.74, E.82, K.85, L.86
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:E.82
DMS.10: 4 residues within 4Å:- Chain B: K.74, E.82, K.85, L.86
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:E.82
DMS.18: 4 residues within 4Å:- Chain C: K.74, E.82, K.85, L.86
1 PLIP interactions:1 interactions with chain C- Salt bridges: C:E.82
DMS.26: 4 residues within 4Å:- Chain D: K.74, E.82, K.85, L.86
1 PLIP interactions:1 interactions with chain D- Salt bridges: D:E.82
- 20 x GOL: GLYCEROL(Non-functional Binders)
GOL.3: 9 residues within 4Å:- Chain A: L.16, K.19, D.98, I.99, G.145, R.147, V.251, S.252, K.253
Ligand excluded by PLIPGOL.4: 8 residues within 4Å:- Chain A: K.157, D.158, F.159, S.160
- Chain C: R.179
- Chain D: D.158, A.270
- Ligands: GOL.28
Ligand excluded by PLIPGOL.5: 3 residues within 4Å:- Chain A: I.71, I.73, Q.89
Ligand excluded by PLIPGOL.6: 6 residues within 4Å:- Chain A: P.162, K.163, H.211, Y.212, I.213, P.214
Ligand excluded by PLIPGOL.7: 7 residues within 4Å:- Chain A: N.154, F.159, G.198, G.199, D.266, A.269
- Ligands: CUE.1
Ligand excluded by PLIPGOL.11: 9 residues within 4Å:- Chain B: L.16, K.19, D.98, I.99, G.145, R.147, V.251, S.252, K.253
Ligand excluded by PLIPGOL.12: 8 residues within 4Å:- Chain B: K.157, D.158, F.159, S.160
- Chain C: D.158, A.270
- Chain D: R.179
- Ligands: GOL.20
Ligand excluded by PLIPGOL.13: 3 residues within 4Å:- Chain B: I.71, I.73, Q.89
Ligand excluded by PLIPGOL.14: 6 residues within 4Å:- Chain B: P.162, K.163, H.211, Y.212, I.213, P.214
Ligand excluded by PLIPGOL.15: 7 residues within 4Å:- Chain B: N.154, F.159, G.198, G.199, D.266, A.269
- Ligands: CUE.9
Ligand excluded by PLIPGOL.19: 9 residues within 4Å:- Chain C: L.16, K.19, D.98, I.99, G.145, R.147, V.251, S.252, K.253
Ligand excluded by PLIPGOL.20: 8 residues within 4Å:- Chain A: R.179
- Chain B: D.158, A.270
- Chain C: K.157, D.158, F.159, S.160
- Ligands: GOL.12
Ligand excluded by PLIPGOL.21: 3 residues within 4Å:- Chain C: I.71, I.73, Q.89
Ligand excluded by PLIPGOL.22: 6 residues within 4Å:- Chain C: P.162, K.163, H.211, Y.212, I.213, P.214
Ligand excluded by PLIPGOL.23: 7 residues within 4Å:- Chain C: N.154, F.159, G.198, G.199, D.266, A.269
- Ligands: CUE.17
Ligand excluded by PLIPGOL.27: 9 residues within 4Å:- Chain D: L.16, K.19, D.98, I.99, G.145, R.147, V.251, S.252, K.253
Ligand excluded by PLIPGOL.28: 8 residues within 4Å:- Chain A: D.158, A.270
- Chain B: R.179
- Chain D: K.157, D.158, F.159, S.160
- Ligands: GOL.4
Ligand excluded by PLIPGOL.29: 3 residues within 4Å:- Chain D: I.71, I.73, Q.89
Ligand excluded by PLIPGOL.30: 6 residues within 4Å:- Chain D: P.162, K.163, H.211, Y.212, I.213, P.214
Ligand excluded by PLIPGOL.31: 7 residues within 4Å:- Chain D: N.154, F.159, G.198, G.199, D.266, A.269
- Ligands: CUE.25
Ligand excluded by PLIP- 4 x CL: CHLORIDE ION(Non-functional Binders)
CL.8: 5 residues within 4Å:- Chain A: G.25, S.26, G.27, Y.49, A.50
Ligand excluded by PLIPCL.16: 5 residues within 4Å:- Chain B: G.25, S.26, G.27, Y.49, A.50
Ligand excluded by PLIPCL.24: 5 residues within 4Å:- Chain C: G.25, S.26, G.27, Y.49, A.50
Ligand excluded by PLIPCL.32: 5 residues within 4Å:- Chain D: G.25, S.26, G.27, Y.49, A.50
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cassetta, A. et al., Crystallographic studies on the flavonoid inhibition of a fungal 17beta-hydroxysteroid dehydrogenase. To be Published
- Release Date
- 2013-07-03
- Peptides
- 17beta-hydroxysteroid dehydrogenase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x CUE: Coumestrol(Non-covalent)
- 4 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- 20 x GOL: GLYCEROL(Non-functional Binders)
- 4 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cassetta, A. et al., Crystallographic studies on the flavonoid inhibition of a fungal 17beta-hydroxysteroid dehydrogenase. To be Published
- Release Date
- 2013-07-03
- Peptides
- 17beta-hydroxysteroid dehydrogenase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A